KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Vertex Pharmaceuticals' Change in Acquisitions & Divestments rose 1950.91% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year increase of 9437.88%. This contributed to the annual value of $4.5 billion for FY2024, which is 43218.93% up from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Change in Acquisitions & Divestments stood at $1.3 billion, which was up 1950.91% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Change in Acquisitions & Divestments registered a high of $1.8 billion during Q2 2025, and its lowest value of $47.2 million during Q4 2021.
  • Its 5-year average for Change in Acquisitions & Divestments is $606.8 million, with a median of $239.8 million in 2023.
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Change in Acquisitions & Divestments crashed by 8135.72% in 2021, and later surged by 132100.0% in 2024.
  • Vertex Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $47.2 million in 2021, then surged by 925.64% to $484.1 million in 2022, then plummeted by 54.95% to $218.1 million in 2023, then soared by 569.51% to $1.5 billion in 2024, then decreased by 8.96% to $1.3 billion in 2025.
  • Its Change in Acquisitions & Divestments was $1.3 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.6 billion in Q1 2025.